NUCB2 and gestational diabetes: A study conducted by Ademoglu et al. in 40 patients with GDM, at a gestational age of between 24–28 weeks, which was similar to the gestational age of the patients enrolled in our study, proved that maternal serum concentrations of nesfatin-1 were lower compared to healthy controls (7.9 (2.8) vs. 11.2 (7.7) ng/mL) [25].